A Study of BB-401 in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Clinical trial NCT03433027 · COMPLETED
Trial details
- NCT number
- NCT03433027
- Sponsor
- Benitec Biopharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2018-12-12
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.